LENSAR Inc (LNSR)

Healthcare | Medical Devices
Latest reporting period: 2026-03-31

Latest Quarter

2026-03-31

Revenue

$13.4M

Net Income

$36.3M

Operating Margin

16.7%

Free Cash Flow

-$2.4M

Debt / Assets

71.9%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for LENSAR Inc (LNSR).
Income Statement (Quarterly) 2026-03-31 2025-03-31 2024-12-31 2024-09-30
Revenue 13,428,000 14,159,000 16,731,000 13,539,000
Cost of Revenue 7,046,000 7,034,000 9,623,000 7,273,000
Gross Profit 6,382,000 7,125,000 7,108,000 6,266,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 2,529,000 11,149,000 6,831,000 6,077,000
Operating Expenses 4,143,000 12,683,000 8,398,000 7,279,000
Operating Income 2,239,000 -5,558,000 -1,290,000 -1,013,000
Interest Expense 0 0 0 0
Income Before Tax 36,332,000 -27,345,000 -18,702,000 -1,502,000
Income Tax Expense 0 0 0 0
Net Income 36,332,000 -27,345,000 -18,702,000 -1,502,000
Per Share
EPS 2.99 -2.32 -1.61 -0.13
EPS Diluted 0.00 0.00 0.00 0.00